Ascending multiple-dose study with ACT-280778, a non-dihydropyridine, dual L/T-type calcium channel blocker: Safety, tolerability, and pharmacokinetics in healthy male subjects

Authors
Category Primary study
ConferenceClinical Pharmacology and Therapeutics
Year 2013
This article has no abstract
Epistemonikos ID: ccc46c6c2088da5adaa249721d91f9b7b467c7d0
First added on: Apr 30, 2026